Klinik fanlar yilnomasi Volume 1 Issue 1 (2024)
EFFICACY OF SLGT2 DRUGS IN TYPE II DIABETES MELLITUS
Ахментаева Д.А, Нұрмахан Ә.К, Мынжасарова М.А
Abstract
SGLT2 was first identified as glucose-lowering drugs due to the glucosuric effect of inhibitors and a good safety profile. Subsequently, the results of studies on the effects of drugs in this group on cardiovascular and renal function began to appear. This article will describe the results of treatment of patients with type 2 diabetes.
chronic heart failure, type 2 diabetes, SGLT-2 drugs, dapagliflozin.хроническая сердечная недостаточность, сахарный диабет II типа, SGLT2 терапия, дапаглифлозинхроническая сердечная недостаточность, сахарный диабет II типа, SGLT2 терапия, дапаглифлозин
Metadata source: the journal's OAI-PMH archive · Sindex does not store the full text; it links to the source.